A Clinical Study of IL13Rα2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I)

Clinical trial NCT05540873 · UNKNOWN

Trial details

NCT number: NCT05540873
Sponsor: CellabMED
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Malignant Glioma

Start date: 2022-07-18
Primary completion: 2024-02-28
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.